Clinical trials
Active, not recruiting Phase 1/2 Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 9 |
| 2021 | 4 |
| 2022 | 5 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Peter MacCallum Cancer Centre, Australia | 2 |
| Acerand Therapeutics (Shanghai) Limited | 1 |
| Antelope Surgical Solutions, Inc | 1 |
| Arsenal Biosciences, Inc. | 1 |
| Cellbion Co., Ltd. | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Five Eleven Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 29 |
| Breast Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Ovarian Neoplasms | 3 |
| Small Cell Lung Carcinoma | 3 |
| Colorectal Neoplasms | 2 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
| Pancreatic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.